Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2024-04-11 00:00:00 ET · period of report 2024-04-09 · accession 0001415889-24-010714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-11 | 2024-04-09 | CTKB | Yan Ming | CTO, Dir | S - Sale | $7.00 | -1,900 | 6.01M | -0.0% | -$13.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-09 | S | D | 400 | $7.01 | 6,008,502 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-09 | S | D | 1,500 | $7.00 | 6,008,902 | D | — | — |